Soligenix, Inc. (SNGX) stock
SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.22−0.02 (-8.29%)
Close on Nov 20, 2026Market cap $4.79MP/E –Yield –
Soligenix free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Soligenix's free cash flow for the twelve months ending Dec 31, 2025 was -$10.27M. For fiscal 2025 it was -$10.27M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.27M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$2.75M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.93M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.20M | – |
See a number that looks wrong?